Analyst Reco.

Mar. 10 CIC Corporate & Institutional Banking Upgrades Ipsen to Buy, Boosts PT MT
Feb. 13 Ipsen Remains in the Green with UBS Support Zonebourse
Feb. 12 Ipsen: Markets applaud strong finish to 2025 and better-than-expected 2026 outlook Alphavalue
Jan. 14 Ipsen, Top Gainer on the SBF 120 and SRD at Wednesday, January 14, 2026 Close Zonebourse
Jan. 14 Ipsen and EMS-Chemie Shine on the Stock Market, Vistry and Pearson Struggle Zonebourse
Jan. 08 UBS No Longer Recommends Buying Ipsen, Citing Full Valuation Zonebourse
Nov. 26 BNP Paribas Downgrades Ipsen to Underperform, Trims PT MT
Nov. 18 AlphaValue/Baader Europe Ups Ipsen's EPS Forecasts After Q3 Beat, 'Substantial' FY25 Outlook Upgrade MT
Nov. 17 Ipsen raises 2025 outlook after stronger Somatuline Alphavalue
Nov. 07 Ipsen to Present Positive Data on PBC at AASLD 2025 Zonebourse
25-10-22 Ipsen: Robust Q3 fuels a guidance upgrade Alphavalue
25-10-13 Ipsen: UBS reiterates buy recommendation Zonebourse
25-09-12 Sadif Investment Analytics Upgrades Ipsen to Hold MT
25-08-13 RBC Keeps Ipsen at Outperform Amid Upcoming Potential Catalysts MT
25-08-12 Ipsen: RBC still a buyer, TP EUR148 Zonebourse
25-07-31 Ipsen: Performance across key offerings fell short of expectations, unsettling investors Alphavalue
25-06-04 Deutsche Bank Restarts Ipsen Coverage with Buy Rating MT
25-06-04 Ipsen: Deutsche Bank resumes coverage as a buyer Zonebourse
25-05-06 RBC Lifts Ipsen Price Target on Iqirvo Q1 Growth, New Indication Opportunity MT
25-05-06 Ipsen: RBC raises target price Zonebourse
25-04-17 AlphaValue/Baader Europe Keeps Buy Rating on Ipsen After Q1 Results MT
25-04-16 Ipsen: In-line Q1; 2025 guidance unchanged Alphavalue
25-04-02 Ipsen: Deutsche Bank upgrades to buy Zonebourse
25-03-28 Ipsen: Ipsen remains a compelling Smaller Pharma investment Alphavalue
25-02-13 Ipsen: Q4 beat led by Somatuline Alphavalue
No results for this search
SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW